186 related articles for article (PubMed ID: 379914)
1. The role of platelets in thrombotic and vascular disease.
Schafer AI; Handin RI
Prog Cardiovasc Dis; 1979; 22(1):31-52. PubMed ID: 379914
[No Abstract] [Full Text] [Related]
2. Antiplatelet therapy.
Sloan RW
Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
[TBL] [Abstract][Full Text] [Related]
3. Aspirin and other platelet-aggregation inhibiting drugs.
Gallus AS
Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet therapy.
Turpie AG
Clin Haematol; 1981 Jun; 10(2):497-520. PubMed ID: 7032786
[No Abstract] [Full Text] [Related]
5. Platelet-active drugs in the secondary prevention of cardiovascular events: an overview.
Weiss HJ
Circulation; 1980 Dec; 62(6 Pt 2):V41-3. PubMed ID: 7002351
[TBL] [Abstract][Full Text] [Related]
6. Status of antiplatelet drugs in coronary heart disease.
Mehta J; Mehta P
JAMA; 1979 Jun; 241(24):2649-51. PubMed ID: 439365
[No Abstract] [Full Text] [Related]
7. Interaction of platelets with subendothelium in humans treated with aspirin and dipyridamole alone or in combination.
Escolar G; Bastida E; Ordinas A; Castillo R
Thromb Res; 1985 Nov; 40(3):419-24. PubMed ID: 4082117
[No Abstract] [Full Text] [Related]
8. Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: a difficult link.
de Gaetano G; Cerletti C; Bertelè V
Lancet; 1982 Oct; 2(8305):974-7. PubMed ID: 6127469
[No Abstract] [Full Text] [Related]
9. [Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
Jobin F
Union Med Can; 1976 Aug; 105(8):1159-73. PubMed ID: 10662
[No Abstract] [Full Text] [Related]
10. Effect of drugs of platelets and complications of vascular disease.
Mustard JF; Packham MA; Kinlough-Rathbone RL
Adv Exp Med Biol; 1977; 82():94-105. PubMed ID: 920448
[No Abstract] [Full Text] [Related]
11. Antiplatelet therapy (first of two parts).
Weiss HJ
N Engl J Med; 1978 Jun; 298(24):1344-7. PubMed ID: 651993
[No Abstract] [Full Text] [Related]
12. The effect of platelet function inhibitors on experimental venous thrombosis formation in rabbits.
Arfors KE; Bergqvist D; Tangen O
Acta Chir Scand; 1975; 141(1):40-2. PubMed ID: 1092111
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet agents: rationale and results.
Kelton JG
Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
[No Abstract] [Full Text] [Related]
14. Drugs in the treatment of thrombo-embolic disease--part I.
Bouchier-Hayes D
Ir Med J; 1983 Feb; 76(2):101-5, 107. PubMed ID: 6601642
[No Abstract] [Full Text] [Related]
15. [Present situation of therapy with platelet aggregation inhibitors].
Poliwoda H
Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157
[No Abstract] [Full Text] [Related]
16. [Summary: Drugs affecting platelet behaviour; experimental and clinical data (author's transl)].
Bouvier CA
Ther Umsch; 1974 Feb; 31(2):84-8. PubMed ID: 4612856
[No Abstract] [Full Text] [Related]
17. Effects of acetylsalicylic acid, sulfinpyrazone and dipyridamole on platelet adhesion and aggregation in flowing native and anticoagulated blood.
Baumgartner HR
Haemostasis; 1979; 8(3-5):340-52. PubMed ID: 511014
[TBL] [Abstract][Full Text] [Related]
18. Clinical aspects of antiplatelet therapy.
Sherry S
Semin Hematol; 1985 Apr; 22(2):125-34. PubMed ID: 3890191
[No Abstract] [Full Text] [Related]
19. Platelet function inhibitors: their clinical use.
Fuster V; Didisheim P
Adv Intern Med; 1978; 23():251-64. PubMed ID: 343540
[No Abstract] [Full Text] [Related]
20. Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis.
Weiss HJ
Am Heart J; 1976 Jul; 92(1):86-102. PubMed ID: 785989
[No Abstract] [Full Text] [Related]
[Next] [New Search]
